Court Place Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Court Place Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,567	Closed	-$354K	–	179
2017 Q4	$354K	Sell	6,567 -444	-6%	-$24.3K	0.15%	123
2017 Q3	$400K	Sell	7,011 -62	-0.9%	-$3.63K	0.18%	114
2017 Q2	$426K	Sell	7,073 -30	-0.4%	-$1.71K	0.2%	107
2017 Q1	$387K	Buy	+7,103	New	+$350K	0.19%	107

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Court Place Advisors's BIVV Position: Q1 2018 in Review

Court Place Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 6,567 shares — an estimated $354K sold.

Court Place Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $426K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Court Place Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Court Place Advisors sold 6,567 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $354K.
Court Place Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Court Place Advisors's Bioverativ Inc. Common Stock position peaked at $426K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Court Place Advisors's 13F filing for Q1 2018, filed 1 May 2018.